Journal article icon

Journal article

Recombinant factor VIIA is used in a Jehova's Witness with liver cirrhosis to correct prothrombin time, bleeding time, and thromboelastographic parameters, enabling safe percutaneous injection of hepatocellular carcinoma

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
Expand authors...
Journal:
THROMBOSIS AND HAEMOSTASIS
Pages:
620-620
Publication date:
1999-08-01
ISSN:
0340-6245
Source identifiers:
66584
Pubs id:
pubs:66584
UUID:
uuid:1b5f95a6-db68-4264-a639-afeebef73d43
Local pid:
pubs:66584
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP